The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD Readmissions

Constantinos Kallis,1– 3 Amit Kaura,1,3 Nathan A Samuel,4 Abdulrahim Mulla,3 Ben Glampson,3 Kevin O’Gallagher,5 Jim Davies,4 Dimitri Papadimitriou,3 Kerrie J Woods,4 Anoop D Shah,6,7 Bryan Williams,6,7 Folkert W Asselbergs,6,7 Erik K Mayer,3,8 Richard W Lee,1,9 Christopher Herbert,10 Stuart W Grant,...

Full description

Bibliographic Details
Published in:	International Journal of COPD
Main Authors:	Kallis C, Kaura A, Samuel NA, Mulla A, Glampson B, O'Gallagher K, Davies J, Papadimitriou D, Woods KJ, Shah AD, Williams B, Asselbergs FW, Mayer EK, Lee RW, Herbert C, Grant SW, Curzen N, Squire IB, Johnson T, Shah AM, Perera D, Kharbanda RK, Patel RS, Channon KM, Mayet J, Quint JK
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-11-01
Subjects:	copd cvd exacerbation
Online Access:	https://www.dovepress.com/the-relationship-between-cardiac-troponin-in-people-hospitalised-for-e-peer-reviewed-fulltext-article-COPD

Similar Items

CLINICAL ROLE OF CARDIAC EXAMINATION IN COPD PATIENTS
by: E. G. Akramova
Published: (2012-02-01)

Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation
by: Tor-Arne Hagve, et al.
Published: (2021-01-01)

Impact of COPD and asthma on in-hospital mortality and management of patients with heart failure in England and Wales: an observational analysis
by: Claudia Gulea, et al.
Published: (2022-06-01)

Association between kidney function, frailty and receipt of invasive management after acute coronary syndrome
by: Richard Lee, et al.
Published: (2024-10-01)

Cardiac Dysfunction Indices and Their Prognostic Value in Acute Exacerbation COPD Patients
by: Ahmad B. Elden, et al.
Published: (2020-01-01)

Enhancing personalised care in COPD exacerbation: the role of cardiac/inflammatory biomarkers
by: Pouria Khashayar, et al.
Published: (2025-07-01)

Cardiac injury in patients with COPD presenting with dyspnea: a pilot study
by: Esosa Odigie-Okon, et al.
Published: (2010-11-01)

Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
by: Fardad Soltani, et al.
Published: (2024-07-01)

Diagnostic and clinical values of non-cardiac ultrasound in COPD: A systematic review
by: Saeed M Alghamdi, et al.
Published: (2020-09-01)

Is COPD the Determinant Factor for Myocardial Injury and Cardiac Wall Stress in OSA Patients?
by: Athanasios Voulgaris, et al.
Published: (2023-10-01)

Systematic review and meta-analysis of prevalence of undiagnosed major cardiac comorbidities in COPD
by: Joseph Kibbler, et al.
Published: (2023-11-01)

Rational use of inhaled corticosteroids for the treatment of COPD
by: Jennifer K. Quint, et al.
Published: (2023-07-01)

Changes in the investigation and management of suspected myocardial infarction and injury during COVID-19: a multi-centre study using routinely collected healthcare data
by: Lara Chammas, et al.
Published: (2024-05-01)

Diagnostic and prognostic value of an ejection fraction adjusted for myocardial remodeling
by: Wei Xuan Chan, et al.
Published: (2024-05-01)

Prognostic significance of troponin in patients with malignancy (NIHR Health Informatics Collaborative TROP-MALIGNANCY study)
by: Nathan A. Samuel, et al.
Published: (2024-07-01)

Association of Race and Major Adverse Cardiac Events (MACE): The Atherosclerosis Risk in Communities (ARIC) Cohort
by: Ericha G Franey, et al.
Published: (2020-01-01)

Cardiac Biomarkers Predict Major Adverse Cardiac Events (MACE) in Incident Haemodialysis Patients: Results from a Global Federated Database
by: Elin Mitford Davies, et al.
Published: (2025-02-01)

Pre-COPD: a New Advance in COPD
by: BAI Yahu, GAO Shenghan, JI Siyu, SHANG Jinyu, DONG Yanchun, NING Kang
Published: (2023-01-01)

National clinical audit for hospitalised exacerbations of COPD
by: John R. Hurst, et al.
Published: (2020-09-01)

Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD
by: Graham S Hillis, et al.
Published: (2021-08-01)

HCKing COPD: unveiling the role of HCK in COPD pathogenesis
by: Richard Y. Kim, et al.
Published: (2025-05-01)

Unravelling young COPD and pre-COPD in the general population
by: Borja G. Cosío, et al.
Published: (2023-02-01)

Blurred lines. Eosinophilic COPD: ACOS or COPD phenotype?
by: C.C. Loureiro
Published: (2016-09-01)

Incidence and prevalence of asthma, COPD, and ILD across England, Wales, and South-East Scotland – a harmonised approach to data analysis
by: Sean Scully, et al.
Published: (2024-09-01)

Major Adverse Cardiovascular Events and Cause-Specific Mortality After Hospitalisation in COPD
by: Ioannides AE, et al.
Published: (2025-07-01)

Structured Cardiac Assessment and Treatment Following Exacerbations of COPD (SCATECOPD): A Pilot Randomised Controlled Trial
by: Joseph Kibbler, et al.
Published: (2025-03-01)

P73 THE ASSESSMENT OF PULMONARY ARTERY STIFFNESS IN COPD USING CARDIAC MRI THE Q/A METHOD
by: Nichola Gale, et al.
Published: (2017-12-01)

Comorbidities and Cause of Death in COPD Patients Compared to Non-COPD Controls: An 8-year Observational Retrospective Healthcare Claims Database Cohort Study
by: Vogelmeier CF, et al.
Published: (2025-06-01)

Biologics in COPD
by: Ana L. Kersul, et al.
Published: (2024-04-01)

Indices and COPD
by: Howard Peter
Published: (2010-06-01)

Comorbidities of COPD
by: Arnaud Cavaillès, et al.
Published: (2013-12-01)

Mepolizumab for Eosinophilic COPD: What Matinee Adds to COPD Management?
by: Isabel Maria Alcázar-Martínez, et al.
Published: (2025-07-01)

Do Antidepressants Worsen COPD Outcomes in Depressed Patients with COPD?
by: Alan G. Kaplan
Published: (2024-11-01)

Chronic obstructive pulmonary disease (COPD) and COPD-like phenotypes
by: Spyridon Fortis, et al.
Published: (2024-04-01)

Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD
by: Laura Miranda de Oliveira Caram, et al.

Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK
by: Rothnie KJ, et al.
Published: (2023-11-01)

Evaluation of Cytokine Levels in Cardiac Transthyretin and Immunoglobulin Light Chain Amyloidosis and Their Correlation with Myocardial Inflammatory Cells and MACE
by: Nicolas Musigk, et al.
Published: (2025-09-01)

M-health for long-term management of COPD
by: Lionel Tarassenko, et al.
Published: (2013-11-01)

Knowledge, attitudes, and practices of COPD patients regarding acute exacerbations of COPD
by: Yuan Xia, et al.
Published: (2025-09-01)

Factors associated with undiagnosed COPD in patients hospitalised for severe COPD exacerbation
by: Thibaud Soumagne, et al.
Published: (2024-12-01)